House of Lords Business
Show full summary

Lord Campbell-Savours to ask Her Majesty's Government whether they plan to publish the details of their contracts with (1) Pfizer/BioNTech for the supply of 30 million MRNA COVID-19 vaccines, (2) Janssen for the supply of 30 million doses  of the AD26COV25 vaccine, (3) GSK Sanofi Pasteur for 60 million doses of the proton adjuvanted vaccine, (4) Novavax for 60 million doses of the NVXCOV2373 vaccines, and (5) Valneva for 60 million doses of the VLA2001 vaccine; if so, (a) when, and (b) how; and if not, why not.  HL12340

Question HL12340: tabled on 20 January 2021 and due for answer by 3 February 2021

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

Lord Campbell-Savours to ask Her Majesty's Government whether they plan to publish the details of their contracts with (1) Pfizer/BioNTech for the supply of 30 million MRNA COVID-19 vaccines, (2) Janssen for the supply of 30 million doses  of the AD26COV25 vaccine, (3) GSK Sanofi Pasteur for 60 million doses of the proton adjuvanted vaccine, (4) Novavax for 60 million doses of the NVXCOV2373 vaccines, and (5) Valneva for 60 million doses of the VLA2001 vaccine; if so, (a) when, and (b) how; and if not, why not.  HL12340
Legend for business item text
† Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Member's Registered Interests

There are no interests to show.

Main Member

Lord Campbell-Savours
Labour
Life peer